Patient-Reported Outcomes from the Randomized Phase Iii Alex Study of Alectinib Versus Crizotinib in Patients with Alk-Positive Non-Small-Cell Lung Cancer

AuthID
P-00R-62M
14
Author(s)
Pérol, M
·
Pavlakis, N
·
Levchenko, E
·
Platania, M
·
Oliveira, J
·
Novello, S
·
Chiari, R
·
Moran, T
·
Mitry, E
·
Liu, T
·
Balas, B
·
Konopa, K
·
Peters, S
Tipo de Documento
Article
Year published
2019
Publicado
in Lung Cancer, ISSN: 0169-5002
Volume: 138, Páginas: 79-87
Indexing
Publication Identifiers
Pubmed: 31654838
SCOPUS: 2-s2.0-85073680178
Source Identifiers
ISSN: 0169-5002
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.